Immune homeostasis and surveillance are fundamental mechanisms that protect from environmental stress, infections and disease. Recent advances have shown us how dysfunction of the immune system and overt inflammation contribute to the development and worsening of major non-communicable diseases, including neurodegenerative disease, cancer, cardiovascular disease, diabetes, and many others.

The purpose of this meeting is to discuss the latest biological breakthroughs in immunology and how these discoveries are being applied to understand and target fundamental pathological mechanisms. We will bring together renowned experts making fundamental breakthroughs in disease areas such as neuro-inflammation, cardiovascular disease and immuno-oncology to discuss the latest advances and highlight areas for future research. We will also learn how these discoveries are being translated into novel therapies that are designed to target key inflammatory pathways and modify human disease.

This SMR meeting will be hosted by the University of Manchester, home of the collaborative centre for inflammation research (MCCIR) and a vibrant and dynamic research community. Bringing together scientists from academia and industry, this programme will highlight many innovative advances in immunology research that will benefit discovery and development of new drugs against major diseases. This meeting will be of interest to students and practicing professionals with an interest in drug discovery and the application of recent insights to advance novel therapeutics.

Please note that places are limited so register early to avoid disappointment.

Fees:
£85 member rate
£135 non member rate

To become a member and
register for the event, pay the special fee of £110